Flow cytometric analysis also demonstrated that the percentage of LGR5-positive cells was significantly reduced by NAC treatment in CCO1 and CCO2 (Figure 6a), suggesting that suppression of ROS reduced the number of cholangiocarcinoma organoids with a stem cell phenotype. This evidence concerns the gene LGR5 and cholangiocarcinoma.